Evidence map›Paper›PMID 41634885›Full record

ArticleAddiction science & clinical practice2026

Grayken lessons: a multidisciplinary approach to care for a patient with severe ketamine use disorder.

Maya Appley, Jessica R Gray, Dima Abdulrahim, Owen Bowden-Jones

Abstract readCase Reports
In one paragraph

Article in Addiction science & clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maya AppleyDivision of General Internal Medicine and Health Services Research, UCLA Health, Los Angeles, USA. mappley@mednet.ucla.edu.
Jessica R GrayDivision of General Internal Medicine, Program for Substance Use and Addiction Services, Massachusetts General Hospital, Boston, USA.
Dima AbdulrahimCentral and North West London NHS Foundation Trust, Club Drug Clinic, London, UK.
Owen Bowden-JonesCentral and North West London NHS Foundation Trust, Club Drug Clinic, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-medical ketamine use is becoming increasingly common in the United States (US), but awareness remains limited among US healthcare providers. CASE PRESENTATION: Here we present the case of a young woman who developed severe ketamine use disorder in the setting of an acute exacerbation of chronic post-traumatic stress disorder (PTSD). She also demonstrated symptoms concerning for two known complications of chronic ketamine use: gastrointestinal toxicity and ketamine-induced uropathy. Informed by best practices established by specialists in club drug use from the United Kingdom (UK), a multidisciplinary care plan was implemented. The plan included specialist referrals for suspected physical complications and connection with a psychiatrist and psychologist to address underlying mental health conditions driving ketamine use. With individualized, multidisciplinary support, she was able to significantly reduce ketamine use, for a period of time.

conclusionsUS healthcare providers must be aware of non-medical ketamine use and associated harms, including ketamine use disorder, in order to provide effective counseling and treatment to increasing numbers of people using ketamine. In the UK, a multidisciplinary clinic was established to serve people struggling with ketamine and other club drug use, providing a model for effective, patient-centered care that can inform our approach to building systems of care for people who use ketamine and other club drugs in the US.

Indexed as

KetaminePatient Care TeamStress Disorders, Post-TraumaticSubstance-Related DisordersAdultFemaleHumansUnited KingdomKetamineClub drugsHarm reductionKetamineMultidisciplinary careSubstance use disorder

Identifiers

PMID41634885
PMCPMC12870938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.